Custom service

Metabolite Identification Platform

Identify and characterize peptide metabolites from in-vitro systems

Turnaround: 3–6 weeksTypical scale: 10^2 – 10^9 members by formatChemistry options: protease and plasma incubation panels; LC-MS/MS metabolite mapping; cleavage-site assignment

Metabolite Identification Platform supports programmes that identify and characterize peptide metabolites from in-vitro systems. In a typical engagement we plan the protease and plasma incubation panels route first, confirm compatibility with LC-MS/MS metabolite mapping, and release metabolite ID report with cleavage map on a 3–6 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep protease and plasma incubation panels as the primary option and hold LC-MS/MS metabolite mapping in reserve, so that scale-up never depends on an unproven step.

Predicting in-vivo degradation pathways

Designing metabolically stable analogs

In-vivo ADME studies

Targets with no assayable readout and no purified protein available

Screening programmes close with a data package: primary screen statistics, confirmation data for each hit, counterscreen results and resynthesized material. Library lots ship with composition QC — representation and identity checks by LC-MS or NGS as the format requires.

Service Highlights

  • Protease and plasma incubation panels as the default route, with LC-MS/MS metabolite mapping held as a proven fallback
  • Cleavage-site assignment worked into the design where the application requires it
  • Every reported hit is confirmed by independent resynthesis and re-testing before it reaches you
  • Analytical confirmation of every intermediate before the final release
  • Library integrity (composition, representation) is measured, not assumed, before screening begins
  • Metabolite ID report with cleavage map delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Library design

    Diversity, degeneracy and deconvolution strategy for Metabolite Identification Platform are fixed in a design document.

  2. Library synthesis or construction

    The library is built with protease and plasma incubation panels and its composition is QC'd before screening.

  3. Primary screening

    Screening runs with LC-MS/MS metabolite mapping, with controls and statistics defined in advance.

  4. Hit deconvolution

    Hits are identified and ranked; counterscreens remove non-specific and promiscuous binders.

  5. Hit confirmation

    Every hit is resynthesized and re-tested; only reproducible hits advance.

  6. Hit delivery

    Confirmed hits and Metabolite ID report with cleavage map are delivered with the full screening data package.

Specifications & timeline

Turnaround
3–6 weeks
Typical scale
10^2 – 10^9 members by format
Chemistry options
protease and plasma incubation panels; LC-MS/MS metabolite mapping; cleavage-site assignment
Deliverable
Metabolite ID report with cleavage map
QC package
Library composition QC, screening raw data, hit confirmation package
Shipping
Ambient (plates, beads) or dry ice (display libraries)

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.